Bain Capital-backed Classys Inc. has acquired JL Health Participacoes S.A., Brazil's largest aesthetic device retailer, for 18.27 billion won, enhancing its presence in the rapidly growing South American market.

Target Information

Bain Capital-backed Classys Inc. has successfully acquired JL Health Participacoes S.A., the largest aesthetic device retailer in Brazil, for 18.27 billion won (approximately $13 million). This acquisition enables Classys to enhance its presence in one of its fastest-growing international markets. Following this all-cash transaction, Classys now owns a 77.5% stake in JL Health, which was achieved after the divestment of the company's non-beauty operations. Additionally, the deal encompasses JL Health’s two subsidiaries and includes a call option to purchase the remaining 22.5% stake.

This acquisition represents a significant advancement in Classys's strategic initiative to create a direct sales network throughout South America. Founded in 2007 and based in Seoul, Classys has established itself as a leader, capturing over 50% of the market share in South Korea’s high-intensity focused ultrasound (HIFU) beauty device segment with its flagship product, the Shurink Universe.

Industry Overview in Brazil

The Brazilian beauty and aesthetics industry is experiencing rapid growth, fueled by increasing consumer interest in cosmetic and aesthetic procedures. This trend reflects a broader rise in the global beauty and wellness market, which has seen signific